BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 16130843)

  • 1. Characteristics of women with gynecologic cancer who enter clinical trials.
    Luck MB; McIntire M; Blades N; Robinson W
    J Reprod Med; 2005 Jul; 50(7):481-5. PubMed ID: 16130843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
    Carney ME; Lancaster JM; Ford C; Tsodikov A; Wiggins CL
    Gynecol Oncol; 2002 Jan; 84(1):36-42. PubMed ID: 11748973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness of gynecologic cancer patients to participate in clinical trials.
    Mathews C; Restivo A; Raker C; Weitzen S; Disilvestro P
    Gynecol Oncol; 2009 Jan; 112(1):161-5. PubMed ID: 18952272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study.
    Moore DH; Kauderer JT; Bell J; Curtin JP; Van Le L
    Gynecol Oncol; 2004 Aug; 94(2):368-74. PubMed ID: 15297174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynecologic cancers.
    Blair AR; Casas CM
    Prim Care; 2009 Mar; 36(1):115-30, ix. PubMed ID: 19231605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of ovarian cancer patients seeking information from a web-based decision support program.
    Markman M; Markman MR; Belland A; Petersen J
    J Womens Health (Larchmt); 2006 Apr; 15(3):312-8. PubMed ID: 16620190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
    Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of the general gynecologist in surgical staging of endometrial cancer: analysis of cost and perioperative outcomes.
    Hoekstra A; Singh DK; Garb M; Arekapudi S; Rademaker A; Lurain JR
    Gynecol Oncol; 2006 Dec; 103(3):897-901. PubMed ID: 16814370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
    Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
    Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial accrual among new cancer patients at a community-based cancer center.
    Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
    Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials.
    Markman M; Petersen J; Montgomery R
    Cancer; 2006 Aug; 107(4):849-53. PubMed ID: 16832813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
    Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
    J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fertility preservation in gynecologic cancer].
    Tropé C; Scheistrøen M; Makar AP
    Tidsskr Nor Laegeforen; 2001 Apr; 121(10):1234-9. PubMed ID: 11402751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility-sparing options for patients with gynecologic malignancies.
    Leitao MM; Chi DS
    Oncologist; 2005 Sep; 10(8):613-22. PubMed ID: 16177285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
    Salani R; Backes FJ; Fung MF; Holschneider CH; Parker LP; Bristow RE; Goff BA
    Am J Obstet Gynecol; 2011 Jun; 204(6):466-78. PubMed ID: 21752752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of gynecologic cancer in elderly patients].
    Ochiai K
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):990-4. PubMed ID: 9644312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do patients with breast cancer participating in clinical trials receive better nursing care?
    Skrutkowska M; Weijer C
    Oncol Nurs Forum; 1997 Sep; 24(8):1411-6. PubMed ID: 9380596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gynecologic cancer in the elderly.
    Termrungruanglert W; Kudelka AP; Edwards CL; Delclos L; Verschraegen CF; Kavanagh JJ
    Clin Geriatr Med; 1997 May; 13(2):363-79. PubMed ID: 9115456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonbreast second malignancies after treatment of primary breast cancer.
    Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.